Cure My Disease

Don't miss your cure!

 Log in / Sign up

New app aims to keep pregnancy weight gain in check

NCT ID NCT05807594

Recruiting now Disease control Sponsor: Penn State University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a digital platform called HMZ 2.0 that helps pregnant women with overweight or obesity manage their weight gain. 144 women will be randomly assigned to use the platform or receive standard pregnancy advice. The platform tracks weight, activity, and eating, and offers personalized coaching from a dietitian. The goal is to see if this approach can help women stay within healthy weight gain guidelines and improve outcomes for both mother and baby.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
digital platform with personalized coaching and monitoring
What this could lead to
If successful, this could provide an effective, scalable tool to help pregnant women manage weight gain, potentially improving health outcomes for mothers and babies.
What could go wrong
This is a relatively small early-stage trial (144 participants), so results may not apply to all pregnant women. The intervention requires daily self-monitoring and weekly sessions, which may be burdensome.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENERGY BALANCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Gestational Weight Gain Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ENERGY BALANCE GESTATIONAL WEIGHT GAIN OVERWEIGHT AND OBESITY PREGNANCY

Contacts and locations

Locations

  • Pennsylvania State University

    RECRUITING

    University Park, Pennsylvania, 16802, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.